Gideon Rodan

Gideon Alfred Rodan ( born June 14, 1934 in Bucharest, † January 1, 2006 in Bryn Mawr, Pennsylvania) was an American biochemist and osteopath.

Rodan studied at the Hebrew University in Jerusalem and at the Weizmann Institute of Science in Rehovot, Israel.

He examined the deformation of bone cells. His most important works analyze osteoporosis and bone loss. Dr. Rodan examined the connection between osteoblasts ( bone cells) and osteoclasts ( cells calcium ), and helped to analyze both types and to describe. He and his team found that a balance between the two species.

In the 1990s, Rodan, now director of the Division of Bone Biology and Osteoporosis at Merck Research Laboratories, a COMPOUND, Fosamax helped to formulate the osteoclast inhibits and reduces bone fragility.

Further work Rodan examined the function of steroids in bone metabolism, and the path on the Konochenzellen communicate with hormones. From 1970 to 1985 he taught at the University School of Dental Medicine in Connecticut, where he headed the Department of Oral Biology. Later he moved to Merck in 2003 he retired.

Rodan 1987 was president of the American Society for Bone and Mineral Research. From 2001 to 2003 he was President of the International Bone and Mineral Society. He was editor of the book Principles of Bone Biology ( 1996).

Dr. Rodan died of cancer in 2006 New Year. He leaves behind his 34 - year-old wife Sevgi, also a biochemist at Merck; a daughter, Aylin Rodan, and a son, Elan Rhodan.

• Man
• Chemists ( 20th century)
• Chemists ( 21st century)
• Americans
• Born in 1934
• Died in 2006